0001701259-19-000002.txt : 20191127 0001701259-19-000002.hdr.sgml : 20191127 20191127123847 ACCESSION NUMBER: 0001701259-19-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191127 DATE AS OF CHANGE: 20191127 EFFECTIVENESS DATE: 20191127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Phage Therapeutics, Inc. CENTRAL INDEX KEY: 0001701259 IRS NUMBER: 814208730 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-313841 FILM NUMBER: 191255439 BUSINESS ADDRESS: STREET 1: 22 FIRSTFIELD ROAD STREET 2: SUITE 125 CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 2408992532 MAIL ADDRESS: STREET 1: 22 FIRSTFIELD ROAD STREET 2: SUITE 125 CITY: GAITHERSBURG STATE: MD ZIP: 20878 D/A 1 primary_doc.xml X0708 D/A LIVE 0001701259 Adaptive Phage Therapeutics, Inc. 22 FIRSTFIELD ROAD SUITE 125 GAITHERSBURG MD MARYLAND 20878 2408992532 DELAWARE None None Corporation true 2017 Gregory Louis Merril 22 Firstfield Road Suite 125 Gaithersburg MD MARYLAND 20878 Executive Officer Director Carl Merril 22 Firstfield Road Suite 125 Gaithersburg MD MARYLAND 20878 Executive Officer Director Raymond Martz 22 Firstfield Road Suite 125 Gaithersburg MD MARYLAND 20878 Director Pharmaceuticals Decline to Disclose 06b true 0001701259-18-000002 2018-01-24 true true false 0 7000000 6994388 5612 false 40 0 0 0 false Adaptive Phage Therapeutics, Inc. /s/ Gregory Louis Merril Gregory Louis Merril CEO 2019-11-27